PREDICT: Preoperative Identification of the Histologically "Vulnerable" Plaque Using Non-invasive Imaging, Biomechanical Assessment and Baroreflex Evaluation in Patients With Severe Carotid Stenosis

Sponsor
IRCCS Policlinico S. Donato (Other)
Overall Status
Recruiting
CT.gov ID
NCT05566080
Collaborator
University of Pavia (Other), Ministry of Health, Italy (Other)
100
1
30.5
3.3

Study Details

Study Description

Brief Summary

Carotid artery stenosis due to atherosclerotic plaques accounts for an important cause of ischemic stroke. Current research seeks to risk stratify asymptomatic patients by characterizing rupture-prone plaques. Currently no single imaging modality can reliably identify those plaques before surgery. Recently, the 3D ultrasound (US) and the assessment of the mechanical stress on the vessel wall have been proposed as non-invasive tools that could play a role in the diagnostic work-up. Data of histological validation, however, are still needed. In this research, 3D US, non-invasive elastography, Finite Element Analysis of computed tomography angiography images and the study of the autonomic cardiovascular control will be used to identify preoperatively the vulnerable plaque in patients undergoing carotid endarterectomy. The results will be compared to that of histology of the removed plaque, aiming to provide a validation to each method for a possible application in the daily practice.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Carotid endarterectomy

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Preoperative Identification of the Histologically "Vulnerable" Plaque Using Non-invasive Imaging, Biomechanical Assessment and Baroreflex Evaluation in Patients With Severe Carotid Stenosis
Actual Study Start Date :
Mar 15, 2021
Anticipated Primary Completion Date :
Sep 30, 2023
Anticipated Study Completion Date :
Sep 30, 2023

Outcome Measures

Primary Outcome Measures

  1. Plaque vulnerability [Through study completion, an average of 3 years]

    To assess the correlation between the result of 3D US in identifying preoperatively the features of vulnerable plaque (plaque volume; presence of a lipidic core/intraplaque hemorrhage/plaque ulceration; fibrous cap thickness) and that of the histological analysis, in patients who will undergo CEA for a 70-99% carotid stenosis. To assess the correlation between the US-SE parameters to plaque vulnerability, as defined by the histological analysis.

  2. Plaque vulnerability [Through study completion, an average of 3 years]

    To assess the state of the autonomic function and cardiovascular control in patients undergoing CEA and check if there is a relation with the histological analysis of the carotid plaque after CEA.

  3. Plaque vulnerability [Through study completion, an average of 3 years]

    To develop software routines to process US B-mode and US-SE images; to determine the mechanical stress patterns on the vessel wall by the different types of carotid plaques through the FEA of preoperative CTA scans of the recruited patients, and their correlation with the plaque histology and 3D US images. relation with the histological analysis of the carotid plaque after CEA.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • age above 18 years;

  • signed informed consent.

Exclusion Criteria:
  • medical conditions limiting expected survival to <1 year;

  • patients with significant uncontrolled or unstable medical condition (heart failure or angina pectoris class NYHA III-IV, cardiac surgery in the previous 30 days, left ventricular ejection fraction <30%, severe chronic obstructive pulmonary disease, myocardial infarction in the previous 30 days, coronary heart disease with revascularization indication, that is, the common trunk or more than two coronary vessels);

  • tracheostomy;

  • paralysis of the laryngeal nerve contralateral to the carotid stenosis;

  • women of childbearing potential;

  • inability to give informed consent;

  • patients presenting contraindications to perform a CTA examination of neck vessels with contrast medium;

  • patients with medical history of stroke/TIA within the previous 6 months.

Contacts and Locations

Locations

Site City State Country Postal Code
1 IRCCS Policlinico San Donato San Donato Milanese Milan Italy 20097

Sponsors and Collaborators

  • IRCCS Policlinico S. Donato
  • University of Pavia
  • Ministry of Health, Italy

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Daniela Mazzaccaro, Principal Investigator, IRCCS Policlinico S. Donato
ClinicalTrials.gov Identifier:
NCT05566080
Other Study ID Numbers:
  • GR-2018-12366862
First Posted:
Oct 4, 2022
Last Update Posted:
Oct 4, 2022
Last Verified:
Sep 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Daniela Mazzaccaro, Principal Investigator, IRCCS Policlinico S. Donato
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 4, 2022